$303.82
6.59% today
NYSE, Aug 22, 10:00 pm CET

Bio-Rad Laboratories, Inc. Class B Stock price

$303.82
+58.35 23.77% 1M
+23.67 8.45% 6M
-24.69 7.52% YTD
-6.21 2.00% 1Y
-196.28 39.25% 3Y
-207.35 40.56% 5Y
+169.02 125.39% 10Y
+248.82 452.40% 20Y
NYSE, Closing price Fri, Aug 22 2025
+18.79 6.59%

Key metrics

Basic
Market capitalization
$7.7b
Enterprise Value
$7.5b
Net debt
positive
Cash
$1.4b
Shares outstanding
27.1m
Valuation (TTM | estimate)
P/E
24.3 | 33.5
P/S
3.0 | 3.0
EV/Sales
3.0 | 3.0
EV/FCF
21.7
P/B
1.1
Financial Health
Equity Ratio
70.2%
Return on Equity
-28.1%
ROCE
3.0%
ROIC
2.4%
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$2.6b | $2.5b
EBITDA
- | $449.8m
EBIT
$288.7m | $302.1m
Net Income
$319.0m | $230.6m
Free Cash Flow
$347.5m
Growth (TTM | estimate)
Revenue
-0.3% | -0.8%
EBITDA
- | 49.0%
EBIT
-15.5% | 1.2%
Net Income
124.1% | 112.5%
Free Cash Flow
95.8%
Margin (TTM | estimate)
Gross
53.0%
EBITDA
- | 17.7%
EBIT
11.3%
Net
12.5% | 9.1%
Free Cash Flow
13.6%
More
EPS
$11.7
FCF per Share
$12.8
Short interest
4.8%
Employees
8k
Rev per Employee
$330.0k
Show more

Is Bio-Rad Laboratories, Inc. Class B a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Bio-Rad Laboratories, Inc. Class B Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Bio-Rad Laboratories, Inc. Class B forecast:

7x Buy
64%
4x Hold
36%

Analyst Opinions

11 Analysts have issued a Bio-Rad Laboratories, Inc. Class B forecast:

Buy
64%
Hold
36%

Financial data from Bio-Rad Laboratories, Inc. Class B

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,554 2,554
0% 0%
100%
- Direct Costs 1,201 1,201
2% 2%
47%
1,354 1,354
2% 2%
53%
- Selling and Administrative Expenses 803 803
1% 1%
31%
- Research and Development Expense 262 262
14% 14%
10%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 289 289
15% 15%
11%
Net Profit 319 319
124% 124%
12%

In millions USD.

Don't miss a Thing! We will send you all news about Bio-Rad Laboratories, Inc. Class B directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bio-Rad Laboratories, Inc. Class B Stock News

Negative
Seeking Alpha
15 days ago
The U.S. Government plans to cut the annual budget allocated to the NIH by 40% in 2026. This decision could have an adverse effect on the operations of Bio-Rad. Bio-Rad projects 0.5% revenue growth for 2025, indicating that it encounters problems in expanding its operations. The four relative valuations conducted in this article reported mixed results. These results suggest that the company tra...
Positive
The Motley Fool
21 days ago
Bio-Rad (BIO) Q2 EPS Jumps 51%
Neutral
Business Wire
21 days ago
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced today that the company's management will host an informational webinar on Bio-Rad's Droplet Digital™ PCR (ddPCR™) product portfolio on Tuesday, August 26, 2025, at 10:00 AM Pacific Time (1:00 PM Eastern Time). The event will i...
More Bio-Rad Laboratories, Inc. Class B News

Company Profile

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Head office United States
CEO Norman Schwartz
Employees 7,700
Founded 1952
Website www.bio-rad.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today